Jump to navigation Jump to search
Mechanism of action
Thrombopoietin receptor agonist
Diseases for which it is used
History of changes in FDA indication
- 2018-07-31: Approved for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
History of changes in PMDA indication
- 2015-09-28: New approval for the improvement of thrombocytopenia in patients with chronic liver disease for whom an elective invasive procedure is planned.
Also known as
- Brand name: Mulpleo, Mulpleta